Q10 Treatment Improved Psychiatric, Clinical Symptoms in Fibromyalgia Patients

Q10 Treatment Improved Psychiatric, Clinical Symptoms in Fibromyalgia Patients
Treatment with the coenzyme Q10 improved a wide range of psychiatric symptoms in patients with fibromyalgia, according to a new study. The treatment also reduced patients' clinical symptoms and inflammation. Based on the results, the researchers may have found a biological explanation for the psychological symptoms associated with the disease, and they suggest that Q10 may offer a psychological and biological therapeutic approach in the same treatment. The work was recently published in the journal CNS Neuroscience & Therapeutics, titled “Effect of coenzyme Q10 on psychopathological symptoms in fibromyalgia patients.” Psychiatric symptoms in fibromyalgia patients, such as depression and anxiety, are still controversial. According to the National Fibromyalgia & Chronic Pain Association (NFMCPA) there is no connection between depression and fibromyalgia, and fibromyalgia is not a psychiatric disorder. The depression associated with fibromyalgia is believed to result from the pain, sleep deprivation, and dysfunction that patients experience. A recent study suggested that oxidative stress (a process that causes cell damage) and mitochondrial dysfunction (leading to energy deficiency in cells) may contribute to fibromyalgia symptoms. In addition, Q10 deficiency has been observed in patients with fibromyalgia. Q10 plays an important role in mitochondrial energy production in the cells, and data has reported improvements of clinical sympto
Subscribe or to access all post and page content.